|
META
|
Communication Services |
DZ Bank |
Downgrade
|
Hold
→
Sell
|
—
|
$1.6T
|
$160.72
|
-1.9%
|
-1.0%
|
+0.5%
|
+0.2%
|
+5.4%
|
+1.0%
|
|
INTC
|
Technology |
Susquehanna |
Downgrade
|
Neutral
→
Negative
|
—
|
$538.0B
|
$39.71
|
-10.3%
|
-8.6%
|
+1.8%
|
-2.6%
|
+1.4%
|
-2.4%
|
|
INTC
|
Technology |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$538.0B
|
$39.71
|
-10.3%
|
-8.6%
|
+1.8%
|
-2.6%
|
+1.4%
|
-2.4%
|
|
QCOM
|
Technology |
DZ Bank |
Downgrade
|
Buy
→
Hold
|
—
|
$216.1B
|
$146.45
|
-1.3%
|
-0.9%
|
+1.6%
|
-0.3%
|
+1.4%
|
+1.2%
|
|
CMCSA
|
Communication Services |
JP Morgan |
Downgrade
|
Overweight
→
Neutral
|
—
|
$90.2B
|
$39.41
|
-0.8%
|
-4.8%
|
-0.0%
|
+0.5%
|
+2.1%
|
+1.2%
|
|
CMCSA
|
Communication Services |
Wolfe Research |
Downgrade
|
Peer Perform
→
Underperform
|
—
|
$90.2B
|
$39.41
|
-0.8%
|
-4.8%
|
-0.0%
|
+0.5%
|
+2.1%
|
+1.2%
|
|
CMCSA
|
Communication Services |
Macquarie |
Downgrade
|
Neutral
→
Underperform
|
—
|
$90.2B
|
$39.41
|
-0.8%
|
-4.8%
|
-0.0%
|
+0.5%
|
+2.1%
|
+1.2%
|
|
ARGX
|
Healthcare |
Baird |
Downgrade
|
Outperform
→
Neutral
|
—
|
$53.1B
|
$372.97
|
-0.8%
|
-2.3%
|
-2.5%
|
+0.8%
|
+3.1%
|
+0.1%
|
|
EW
|
Healthcare |
Canaccord Genuity |
Downgrade
|
Buy
→
Hold
|
—
|
$48.1B
|
$107.29
|
-6.8%
|
-6.3%
|
-1.1%
|
+2.8%
|
+1.2%
|
+1.4%
|
|
ROKU
|
Communication Services |
Evercore ISI |
Downgrade
|
Outperform
→
In Line
|
—
|
$18.2B
|
$85.17
|
-22.4%
|
-23.1%
|
+9.4%
|
+5.6%
|
+4.3%
|
+2.9%
|
|
ROKU
|
Communication Services |
Susquehanna |
Downgrade
|
Positive
→
Neutral
|
—
|
$18.2B
|
$85.17
|
-22.4%
|
-23.1%
|
+9.4%
|
+5.6%
|
+4.3%
|
+2.9%
|
|
SWK
|
Industrials |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$11.2B
|
$98.58
|
-1.0%
|
-1.3%
|
-0.2%
|
-3.2%
|
-0.4%
|
-0.0%
|
|
SWK
|
Industrials |
Vertical Research |
Downgrade
|
Buy
→
Hold
|
—
|
$11.2B
|
$98.58
|
-1.0%
|
-1.3%
|
-0.2%
|
-3.2%
|
-0.4%
|
-0.0%
|
|
GDS
|
Technology |
Nomura Instinet |
Downgrade
|
Buy
→
Neutral
|
—
|
$8.3B
|
$28.07
|
-6.8%
|
-1.4%
|
-2.7%
|
+6.1%
|
+1.9%
|
+0.3%
|
|
JHG
|
Financial Services |
Citigroup |
Downgrade
|
Neutral
→
Sell
|
—
|
$7.9B
|
$25.33
|
-0.5%
|
+1.7%
|
+3.1%
|
-2.1%
|
-1.5%
|
-2.7%
|
|
TFX
|
Healthcare |
Wells Fargo |
Downgrade
|
Overweight
→
Equal Weight
|
—
|
$5.9B
|
$245.69
|
-1.5%
|
-2.1%
|
+2.0%
|
+2.3%
|
+1.6%
|
-1.7%
|
|
FND
|
Consumer Cyclical |
Piper Sandler |
Downgrade
|
Overweight
→
Neutral
|
—
|
$4.8B
|
$79.07
|
-2.4%
|
+1.9%
|
+0.5%
|
-0.4%
|
+3.7%
|
-2.2%
|
|
WING
|
Consumer Cyclical |
Stifel |
Downgrade
|
Buy
→
Hold
|
—
|
$3.6B
|
$119.80
|
-1.0%
|
+5.3%
|
-6.3%
|
+4.8%
|
+4.8%
|
-0.1%
|
|
EEFT
|
Technology |
Wolfe Research |
Downgrade
|
Outperform
→
Peer Perform
|
—
|
$3.1B
|
$97.35
|
-2.0%
|
+0.9%
|
-2.3%
|
+0.1%
|
+2.3%
|
-1.0%
|
|
HTGC
|
Financial Services |
Oppenheimer |
Downgrade
|
Outperform
→
Perform
|
—
|
$3.0B
|
$15.56
|
+1.2%
|
+2.2%
|
+1.4%
|
-2.6%
|
+0.3%
|
-1.1%
|